Enhatch is a venture-funded company that specializes in 3D planning for 3D printed implants and surgical guides. Founded in 2012 and headquartered in the United States, Enhatch aims to revolutionize the field of surgery by making it faster, safer, and smarter. The company offers streamlined solutions for handling all 3D planning needs for patient-specific solutions, including 3D printed implants, surgical guides, and anatomic models used in orthopedic, spine, and various surgical procedures. In addition to its innovative products, Enhatch's intelligent technology suite offers various benefits such as streamlining surgery scheduling and forecasting, facilitating better communication between sales representatives and surgeons, and enhancing field inventory management with 100% last-mile visibility. The company recently received a significant $9.00M Series A investment on 22 June 2021 from Numeta Capital and Apis Holdings. With a focus on the Health Care and Mobile industries, Enhatch is well-positioned to make a lasting impact in the medical technology sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | $9.00M | 2 | 22 Jun 2021 | |
Seed Round | Unknown | 3 | 15 Sep 2017 | |
Seed Round | Unknown | 1 | 28 Oct 2016 | |
Seed Round | Unknown | 3 | 07 Mar 2016 | |
Seed Round | Unknown | 1 | 19 Nov 2015 |
No recent news or press coverage available for Enhatch.